Insulin analogues. A critical review

Area of Science:

• Endocrinology
• Pharmacology
• Diabetology

Background:

• The last decade has seen significant technological innovations in insulin therapy.
• Development of insulin analogues with novel pharmacokinetic profiles.

Purpose of the Study:

• To review recent advancements in insulin therapy, focusing on novel insulin analogues.
• To discuss the pharmacokinetic properties and clinical implications of new insulin formulations.
• To explore alternative insulin delivery routes.

Main Methods:

• Review of scientific literature on insulin analogues and novel insulin delivery systems.
• Analysis of pharmacokinetic data and clinical trial results for new insulin formulations.
• Discussion of comparative studies between insulin analogues and regular insulin.

Main Results:

• Insulin lispro and insulin aspart exhibit rapid action, requiring careful administration protocols.
• New ultralong-acting insulin analogues provide sustained, peakless action, reducing hypoglycemia.
• Novel insulin molecules conjugated with thyroxin or fatty acids demonstrate prolonged effects and potentially selective action.

Conclusions:

• Technological innovations have significantly advanced insulin therapy, offering improved glycemic control and safety.
• Proper understanding of pharmacokinetic profiles is crucial for optimizing insulin analogue efficacy.
• Emerging insulin formulations and delivery methods hold promise for enhanced diabetes management.